Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

A randomized controlled trial to assess safety, tolerability, and antepartum viral load with increased lopinavir/ritonavir dosage in pregnancy.

Bonafe SM, Costa DA, Vaz MJ, Senise JF, Pott-Junior H, Machado RH, Castelo A.

AIDS Patient Care STDS. 2013 Nov;27(11):589-95. doi: 10.1089/apc.2013.0159.

2.

Antiretroviral treatment of maternal HIV infection.

Talaie H, Nava-Ocampo AA, Koren G.

Can Fam Physician. 2004 Jun;50:865-8. Review.

3.

Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.

Hsyu PH, Schultz-Smith MD, Lillibridge JH, Lewis RH, Kerr BM.

Antimicrob Agents Chemother. 2001 Dec;45(12):3445-50.

4.

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.

Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE.

AIDS. 2000 Mar 10;14(4):F63-7.

5.

New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review.

Lee EC, Walmsley S, Fantus IG.

CMAJ. 1999 Jul 27;161(2):161-4. Review. No abstract available.

6.

Insulin resistance in HIV protease inhibitor-associated diabetes.

Yarasheski KE, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J, Halban PA, Cryer PE, Powderly WG.

J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):209-16.

Items per page

Supplemental Content

Support Center